Focus Financial Network, Inc. Gilead Sciences, Inc. Transaction History

Focus Financial Network, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jul 24, 2024	BUY	$62.32 - $89.47 $154,615 - $221,975	2,481 New	2,481 $213 Million
Q3 2022 Jul 24, 2024	SELL	$59.54 - $68.01 $46,738 - $53,387	-785 Reduced 15.77%	4,194 $259 Million
Q2 2022 Jul 24, 2024	BUY	$57.72 - $65.01 $50,562 - $56,948	876 Added 21.35%	4,979 $308 Million
Q1 2022 Jul 24, 2024	BUY	$57.92 - $72.58 $60,063 - $75,265	1,037 Added 33.82%	4,103 $244 Million
Q4 2021 Jul 24, 2024	BUY	$64.88 - $73.64 $198,922 - $225,780	3,066 New	3,066 $223 Million
Q2 2021 Jul 24, 2024	SELL	$63.47 - $69.35 $232,681 - $254,237	-3,666 Closed	0 $0
Q1 2021 Jul 24, 2024	BUY	$60.0 - $68.46 $219,960 - $250,974	3,666 New	3,666 $237 Million
Q3 2020 Jul 24, 2024	SELL	$62.1 - $78.08 $304,227 - $382,513	-4,899 Closed	0 $0
Q2 2020 Jul 24, 2024	BUY	$72.34 - $84.0 $36,821 - $42,756	509 Added 11.59%	4,899 $377 Million
Q1 2020 Jul 24, 2024	BUY	$62.63 - $80.22 $274,945 - $352,165	4,390 New	4,390 $328 Million
Q2 2019 Jul 24, 2024	SELL	$61.87 - $69.38 $206,212 - $231,243	-3,333 Closed	0 $0
Q1 2019 Jul 24, 2024	BUY	$62.53 - $70.05 $208,412 - $233,476	3,333 New	3,333 $217 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Focus Financial Network, Inc., based on Form 13F filings with the SEC.

Stay updated on Focus Financial Network, Inc. with notifications on news.